Related references
Note: Only part of the references are listed.Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies
Meng Yuan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test
Antonin Bal et al.
CLINICAL CHEMISTRY (2021)
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
Alicia T. Widge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan et al.
SCIENCE (2021)
Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design
Xuhua Xia
VIRUSES-BASEL (2021)
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses
Agnes Bonifacius et al.
IMMUNITY (2021)
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
Florian Krammer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Vaccine efficacy probable against COVID-19 variants
Larry L. Luchsinger et al.
SCIENCE (2021)
Breadth and function of antibody response to acute SARS-CoV-2 infection in humans
Kuan-Ying A. Huang et al.
PLOS PATHOGENS (2021)
Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination
Venkata Viswanadh Edara et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
PFIZER COVID VACCINE PROTECTS AGAINST WORRYING VARIANTS
Ewen Callaway
NATURE (2021)
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
Laith J. Abu-Raddad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
William N. Voss et al.
SCIENCE (2021)
A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
Chunyan Wang et al.
NATURE COMMUNICATIONS (2021)
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
Fatima Amanat et al.
CELL (2021)
Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer
Thomas Mueller
CLINICA CHIMICA ACTA (2021)
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
Jianying Liu et al.
NATURE (2021)
COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
Pinja Jalkanen et al.
NATURE COMMUNICATIONS (2021)
Variable Performance in 6 Commercial SARS-CoV-2 Antibody Assays May Affect Convalescent Plasma and Seroprevalence Screening
Megan Zilla et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
A human monoclonal antibody blocking SARS-CoV-2 infection
Chunyan Wang et al.
NATURE COMMUNICATIONS (2020)
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Yuan Huang et al.
ACTA PHARMACOLOGICA SINICA (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu et al.
NATURE (2020)
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Kizzmekia S. Corbett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evaluation of SARS-CoV-2 prototype serologic test in hospitalized patients
Sarah E. Wheeler et al.
CLINICAL BIOCHEMISTRY (2020)
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
Ching-Lin Hsieh et al.
SCIENCE (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes et al.
NATURE (2020)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Ugur Sahin et al.
NATURE (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
On the use of nonparametric tests for comparing immunological Reverse Cumulative distribution curves (RCDCs)
Robert D. Small et al.
VACCINE (2019)